Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 803 results for "sandoz inc"

A riddle wrapped in a mystery inside an enigma: the Federal Ci...

, the Federal Circuit issued a divided decision in Amgen Inc. v. Sandoz Inc. , No. 15-1499 (Fed. Cir. July 21, 2015), interpreting two provisions of the Biologics Price Competition and Innovation Act (BPCIA).The Federal Circuit decided two issues: ... Lexology, 19 hours ago

5 images for sandoz inc

PRWeb UK, 2 weeks ago
MSN News US, 1 month ago
Maryland Gazette, 3 months ago, 4 months ago, 6 months ago

Sandoz to distribute Medicines Company's anticoagulant in US

The Medicines Company, a biopharmaceutical company, has signed an agreement with Sandoz Inc. for the distribution of an authorized generic of its anticoagulant, ANGIOMAX, or bivalirudin, for injection, in the US. "Bivalirudin has become a foundation ...
 Individual.com1 week ago MEDICINES : DE : Entry into a Material Definitive Agreement, Other Events (form 8-K)  4 Traders2 weeks ago

Patent litigants feeling effects of Teva in claim construction decisions on appeal

In January 2015, the U.S. Supreme Court handed down its decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. , holding that underlying factual disputes related to a district court's claim construction should be reviewed for clear error instead ...
 Lexology1 week ago Intellectual Property Alert: Federal Circuit Holds Claims Indefinite Based on Prosecution History in Teva Pharmaceuticals USA v. Sandoz, Inc.  JD Supra3 weeks ago

The Medicines Company Authorizes Generic Launch of Angiomax

— TheMedicines Companyannounced an agreement July 9 with Sandoz Inc. for the distribution of an authorized generic of Angiomax (bivalirudin) for injection in the United States. Angiomax is indicated in patients undergoing percutaneous coronary ...
 Diagnostic & Invasive Cardiology6 days ago Medicines Co. Authorizes Generic Launch Of Angiomax  RTTNews.com2 weeks ago The Medicines Company (MDCO) Authorizes Generic Launch of ANGIOMAX (Bivalirudin) 7/9/2015  ClinicSpace2 weeks ago MEDICINES : Authorizes Generic Launch of ANGIOMAX® (bivalirudin)  4 Traders2 weeks ago

Sandoz Inc recalls India-made anti-allergic tablets in US

NEW DELHI: Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity concerns. According to information on the USFDA site, the recall is for Cetirizine HCl chewable tablets of 10 ...
 Economic Times1 month ago

Novartis, Tory Burch, Ashley Madison Hack: Intellectual Property

Novartis AG's Sandoz unit may begin selling the first copy of Amgen Inc.'s cancer treatment Neupogen as soon as Sept. 2 after an appeals court ruling Tuesday rejected arguments that it failed to follow regulatory rules. Sandoz didn't violate the ...
 Boe Report1 week ago Novartis May Sell Copy of Amgen's Neupogen Drug in September  La Repubblica1 week ago

Biosimilars & Biobetters USA: Hear from Sandoz, MedImmune, Selecta Biosciences, Bristows LLP, BioInsight Inc

PRWeb SMi's conference on Biosimilars & Biobetters USA 2015 will be taking place in Renaissance Woodbridge Hotel in Iselin, New Jersey, USA, on the 16th and 17th of November 2015. The 2-day event programme will offer effective strategies and ...
 Wall Street Business Network2 weeks ago

Novartis blocked from selling Neupogen copycat until September

Novartis AG unit Sandoz must wait until September to sell Zarxio, the first biosimiar drug approved in the United States and a copycat version of Amgen Inc's Neupogen, a U.S. appeals court said on Tuesday. Ruling in a patent infringement lawsuit ...
 Reuters1 week ago UPDATE 1-Novartis blocked from selling Neupogen copycat until Sept. 2  CNBC1 week ago Novartis AG Thwarted From Selling Amgen's Neupogen Until September  BioSpace1 week ago Novartis AG (NVS) Thwarted From Selling Amgen (AMGN)'s Neupogen Until September 7/22/2015  ClinicSpace1 week ago
SPi World News

Amgen : Fitch Affirms Amgen Inc.'s Ratings at 'BBB'; Outlook Revised to Stable

The following is from Fitch Ratings on July 15 : Fitch Ratings has affirmed Amgen Inc.'s ( Amgen's ) ratings, including the 'BBB'/'F2' Issuer Default Rating (IDR). The Rating Outlook has been revised to Stable from Negative as a result of Amgen's ...
 4 Traders1 week ago Fitch Affirms Amgen Inc.'s Ratings at 'BBB'; Outlook Revised to Stable  CNBC2 weeks ago

Premarket Biotech Digest: Pfizer In China, Anavex Alzheimer's Focus

Jul. 14, 2015 8:14 AM ET | About: Pfizer Inc. (PFE), Includes: ANAC, AVXL, AZN, LFCYF, OTSKY, XOMA by: Kanak Kanti De Summary Today's digest discusses Pfizer's operations in China amidst the slump. Introduces Anavex, a company developing an ...
 Seeking Alpha2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less